Exosome Science

Exosomes That Rebalance. Not Just Suppress.

Stem cells are natural communicators. 

To maintain tissue homeostasis, they continuously secrete exosomes 

— nanoscale vesicles carrying bioactive signals 

that instruct neighboring cells to respond, repair, and rebalance.



At Akrocell, we isolate these functional signaling molecules 

from species-specific stem cells 

through a controlled, commercial-scale manufacturing process 

— and develop them into therapeutic agents.



The result is a cell-free biologic that carries the regenerative intelligence of stem cells, 

without the cells themselves.



Our focus is on one defining property: immunomodulation.



In companion animals with chronic immune-mediated conditions, 

the immune system does not simply need to be suppressed 

— it needs to be rebalanced. 


Existing treatments block single targets. 

Our exosomes act across multiple pathways simultaneously, 

working to restore immune equilibrium rather than override it.

                       Multi-pathway

                                            Acts across immune signaling networks, not a single target



                       Species-specific cargo

                                            Exosomal miRNA profiles differ by species, driving species-specific biological responses



                       Immunomodulation, not immunosuppression

                                            Restoring balance, not shutting down defense

Exosome Science

Exosomes That Rebalance. 

Not Just Suppress.

Stem cells are natural communicators. To maintain tissue homeostasis, they continuously secrete exosomes — nanoscale vesicles carrying bioactive signals that instruct neighboring cells to respond, repair, and rebalance.


At Akrocell, we isolate these functional signaling molecules from species-specific stem cells through a controlled, commercial-scale manufacturing process — and develop them into therapeutic agents.


The result is a cell-free biologic that carries the regenerative intelligence of stem cells, without the cells themselves.


 Our focus is on one defining property: immunomodulation.


In companion animals with chronic immune-mediated conditions, the immune system does not simply need to be suppressed — it needs to be rebalanced. 


Existing treatments block single targets. Our exosomes act across multiple pathways simultaneously, working to restore immune equilibrium rather than override it.

Multi-pathway

Acts across immune signaling networks, not a single target



Species-specific cargo

Exosomal miRNA profiles differ by species, driving species-specific biological responses



Immunomodulation, 

not immunosuppression

Restoring balance, not shutting down defense

Akrocell Biosciences, Inc.

Suite 103, Business Incubation Center, Biopharma HQ, Jeonnam Bio Foundation, 

12-55, Sandan-gil, Hwasun, Jeonnam 58141, Republic of Korea
T. +82 (0)31 423 3730 ㅣ F. +82 (0)504 293 0219 ㅣ 

E. admin@akrocell.com

COPYRIGHT © 2026 Akrocell Biosciences, Inc. 

ALL RIGHTS RESERVED.

Akrocell Biosciences, Inc.
Suite 103, Business Incubation Center, Biopharma HQ, Jeonnam Bio Foundation, 

12-55, Sandan-gil, Hwasun, Jeonnam 58141, Republic of Korea
T. +82 (0)31 423 3730
 ㅣ F. +82 (0)504 293 0219  E. admin@akrocell.com

COPYRIGHT © 2026 Akrocell Biosciences, Inc. ALL RIGHTS RESERVED.